David G. Nathan , MD
|
President Emeritus, Dana-Farber Cancer Institute
Office Phone: 617-632-2155
Appointment Line: 617-355-8246 (Ext. 2)
Fax: 617-632-2161
NPI: 1487717179 |
Departments/Divisions
Specialties
aplastic anemia
hematology/oncology
sickle cell disease
thalassemia
Services/Programs
Academic Appointments
Robert A. Stranahan Distinguished Professor of Pediatrics, Harvard Medical School
Certifications
Internal Medicine, Pediatrics
Medical School
Harvard Medical School, Boston, MA
(1955)
Internship
Brigham and Women's Hospital, Boston, MA
(1955-1956)
Residency
Brigham and Women's Hospital, Boston, MA
(1958 to 1959)
Fellowship
National Cancer Institute, Bethesda, MD
(1956-1958)
Bone Marrow Failure Syndromes, Iron Chelators, Public Policy Regarding Clinical Research
- Blackfan-Diamond anemia (Medicine 75:77, 1996; Blood 97:2145, 2001)
- Public policy on clinical research (JAMA 280:1427, 1998; Nat Med 6:1201, 2000; JAMA 285:533, 2001; N Engl J Med 346:372, 2002; JAMA 287:2424, 2002; N Engl J Med 349: 1860, 2003; J Clin Invest 115:795, 2005; JAMA 295:2656,2006)
- Deferiprone vs desferrioxamine as iron chelators (Lancet 361:183, 2003; Blood 101:5089, 2003)
- Development and double blind test of a new oral iron chelator, ICL670. Lancet 361:1597, 2003)
Research site for David Nathan, MD
www.childrenshospital.org/cfapps/research/data_admin/Site309/mainpageS309P0.html
-
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215Phone: 617-632-2155Fax: 617-632-2161